Pages that link to "Q37794004"

The following pages link to Aerosol delivery to ventilated newborn infants: historical challenges and new directions (Q37794004):

Displaying 24 items.

• Fundamentals of aerosol therapy in critical care (Q28068836) (← links)
• Utilization of inhaled corticosteroids for infants with bronchopulmonary dysplasia (Q28542831) (← links)
• Optimal delivery of aerosols to infants during mechanical ventilation. (Q34488035) (← links)
• Development of a new technique for the efficient delivery of aerosolized medications to infants on mechanical ventilation (Q34861310) (← links)
• In vitro surfactant and perfluorocarbon aerosol deposition in a neonatal physical model of the upper conducting airways. (Q35248188) (← links)
• Generating Charged Pharmaceutical Aerosols Intended to Improve Targeted Drug Delivery in Ventilated Infants (Q35934835) (← links)
• In Vitro Evaluation of a Device for Intra-Pulmonary Aerosol Generation and Delivery (Q36578605) (← links)
• Neonatal non-invasive respiratory support: physiological implications (Q37145611) (← links)
• Delivery and performance of surfactant replacement therapies to treat pulmonary disorders (Q37341712) (← links)
• Inhaled Vitamin D: A Novel Strategy to Enhance Neonatal Lung Maturation (Q37538301) (← links)
• Aerosol delivery to intubated patients (Q38101349) (← links)
• Challenges Associated with Route of Administration in Neonatal Drug Delivery. (Q38561363) (← links)
• Aerosol delivery of synthetic lung surfactant. (Q40300928) (← links)
• Aerosolized KL4 surfactant improves short-term survival and gas exchange in spontaneously breathing newborn pigs with hydrochloric acid-induced acute lung injury (Q42618365) (← links)
• In Vitro Assessment of Small Charged Pharmaceutical Aerosols in a Model of a Ventilated Neonate. (Q47220715) (← links)
• In vitro and in vivo characterization of poractant alfa supplemented with budesonide for safe and effective intratracheal administration. (Q47828098) (← links)
• [Efficacy of different preparations of budesonide combined with pulmonary surfactant in the treatment of neonatal respiratory distress syndrome: a comparative analysis]. (Q53102519) (← links)
• Antenatal hypoxia and pulmonary vascular function and remodeling. (Q55110701) (← links)
• The Effect of Inhaled Budesonide on the Prevention of Chronic Lung Disease in Premature Neonates with Respiratory Distress Syndrome. (Q55263106) (← links)
• Respiratory Care for the Ventilated Neonate (Q56967393) (← links)
• Experimental Evaluation of Perfluorocarbon Aerosol Generation with Two Novel Nebulizer Prototypes (Q61805599) (← links)
• Surfactant replacement therapy in combination with different non-invasive ventilation techniques in spontaneously-breathing, surfactant-depleted adult rabbits (Q89998824) (← links)
• In Vitro Performance of an Investigational Vibrating-Membrane Nebulizer with Surfactant under Simulated, Non-Invasive Neonatal Ventilation Conditions: Influence of Continuous Positive Airway Pressure Interface and Nebulizer Positioning on the Lung D (Q90361913) (← links)
• A novel delivery system for supraglottic atomization allows increased lung deposition rates of pulmonary surfactant in newborn piglets (Q91566783) (← links)